Novel Microdevices Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$500K
- Investors
-
8
Novel Microdevices General Information
Description
Developer of a handheld medical device designed to facilitate molecular diagnostics. The company's device uses microfluidics to analyze a raw biological sample directly at the point of care and takes only half an hour to interpret quality results, enabling healthcare professionals to ensure accurate results in a lab-free environment.
Contact Information
Website
www.noveldx.comCorporate Office
- 101 West Dickman Street
- Suite 300
- Baltimore, MD 21230
- United States
Corporate Office
- 101 West Dickman Street
- Suite 300
- Baltimore, MD 21230
- United States
Novel Microdevices Timeline
Novel Microdevices Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 19-Apr-2026 | $500K | Completed | Generating Revenue | ||
| 6. Debt - General | 07-Jan-2025 | Completed | Generating Revenue | |||
| 5. Grant | 11-Nov-2024 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 04-Jan-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Grant | 06-Apr-2021 | $3.6M | Completed | Generating Revenue | ||
| 1. Grant | 01-Jan-2021 | $2.53M | Completed | Startup |
Novel Microdevices Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-1 | ||||||||
| Series A | 1,778,067 | $0.000010 | $1.95 | $1.95 | 1x | $1.95 | 10.47% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Novel Microdevices Comparisons
Industry
Financing
Details
Novel Microdevices Competitors (8)
One of Novel Microdevices’s 8 competitors is Rheonix, a Venture Capital-Backed company based in Ithaca, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rheonix | Venture Capital-Backed | Ithaca, NY | ||||
| ACON Laboratories | Corporate Backed or Acquired | San Diego, CA | ||||
| RICOVR Healthcare | Venture Capital-Backed | Princeton, NJ | ||||
| Chronus Health | Venture Capital-Backed | Fremont, CA | ||||
| Nuclein | Venture Capital-Backed | Austin, TX |
Novel Microdevices Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Novel Microdevices Patents
Novel Microdevices Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022378707-A1 | Apparatus for containing and dispensing reagent into a microfluidic cartridge for use in point-of-care devices | Pending | 01-Nov-2021 | ||
| CA-3236941-A1 | Apparatus for containing and dispensing reagent into a microfluidic cartridge for use in point-of-care devices | Pending | 01-Nov-2021 | ||
| EP-4427054-A2 | Apparatus for containing and dispensing reagent into a microfluidic cartridge for use in point-of-care devices | Pending | 01-Nov-2021 | ||
| EP-4427054-A4 | Apparatus for containing and dispensing reagent into a microfluidic cartridge for use in point-of-care devices | Pending | 01-Nov-2021 | ||
| US-20240351040-A1 | Apparatus for containing and dispensing reagent into a microfluidic cartridge for use in point-of-care devices | Pending | 01-Nov-2021 | B01L3/523 |
Novel Microdevices Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Novel Microdevices Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| Ecphora Capital | Venture Capital | Minority | ||
| Old Line Capital Partners | Venture Capital | Minority | ||
| TEDCO | Venture Capital | Minority | ||
| Smart City Works | Accelerator/Incubator |
Novel Microdevices FAQs
-
When was Novel Microdevices founded?
Novel Microdevices was founded in 2014.
-
Where is Novel Microdevices headquartered?
Novel Microdevices is headquartered in Baltimore, MD.
-
What is the size of Novel Microdevices?
Novel Microdevices has 45 total employees.
-
What industry is Novel Microdevices in?
Novel Microdevices’s primary industry is Diagnostic Equipment.
-
Is Novel Microdevices a private or public company?
Novel Microdevices is a Private company.
-
What is Novel Microdevices’s current revenue?
The current revenue for Novel Microdevices is .
-
How much funding has Novel Microdevices raised over time?
Novel Microdevices has raised $8.67M.
-
Who are Novel Microdevices’s investors?
National Institutes of Health, Ecphora Capital, Old Line Capital Partners, TEDCO, and Smart City Works are 5 of 8 investors who have invested in Novel Microdevices.
-
Who are Novel Microdevices’s competitors?
Rheonix, ACON Laboratories, RICOVR Healthcare, Chronus Health, and Nuclein are some of the 8 competitors of Novel Microdevices.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
